News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NeuroPace, Inc.
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
April 17, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
March 05, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
December 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
December 01, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
November 06, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Announces RNS System Enhancements Designed to Streamline Care
October 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Participate in Upcoming Investor Conferences
August 24, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
August 08, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
July 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Announces CEO Transition
June 28, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
May 24, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
May 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
April 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 03, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
March 02, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 10, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
January 09, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now Underway
November 30, 2022
From
NeuroPace, Inc.
Via
Business Wire
Tickers
NPCE
NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business Update
November 08, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference
November 04, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022
October 25, 2022
From
NeuroPace, Inc.
Via
GlobeNewswire
Tickers
NPCE
NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized Epilepsy (IGE)
October 11, 2022
From
NeuroPace, Inc.
Via
Business Wire
Tickers
NPCE
NeuroPace Announces First Patient Treated in Pivotal Study Evaluating the RNS System in Adolescents
May 04, 2022
From
NeuroPace, Inc.
Via
Business Wire
Tickers
NPCE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close